Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
Abstract Squamous cell carcinoma is the most frequent histologic type of anal carcinoma. The standard of care since the 1970s has been a combination of 5-fluorouracil, mitomycin C, and radiotherapy. This treatment is very effective in T1/T2 tumors (achieving complete regression in 80–90% of tumors)....
Guardado en:
Autores principales: | Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Joan Maurel, Rocio Garcia-Carbonero, Jaume Capdevila, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Miriam Cuatrecasas, Pilar García-Alfonso, Ricardo Ramos-Ruiz, Carlos Llorens, Ismael Ghanem, Carles Conill, Victoria Heredia-Soto, Ángel Campos-Barros, Juan Ángel Fresno Vara, Jaime Feliu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4fe26f9fdff4908953ce34c605cf410 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
por: George P Kim, et al.
Publicado: (2008) -
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
por: Hendrikx JJMA, et al.
Publicado: (2020) -
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
por: Liao MZ, et al.
Publicado: (2020) -
The Gonyautoxin 2/3 epimers reduces anal tone when injected in the anal sphincter of healthy adults
por: GARRIDO,ROGELIO, et al.
Publicado: (2004) -
Bibliotecas. Anales de investigación /
Publicado: (2017)